← All stocks

uniQure N.V.

QURE Net selling
CIK 0001590560 #1650 in the set updated 18 Sep 2026
Bought (120 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$80.76M
$245.49K on a plan · $42.95M straight out of an exercise
Sold at will
$37.56M
277 of 377 sales
Net
−$80.76M
−$37.56M against sales at will

By person

25 insiders · 377 transactions
35.2×

Matthew Kapusta holds 35.2 times base salary in stock. $23.83M of shares against $676.17K in salary for 2025.

Salary from the company's own proxy. The shares are what Matthew Kapusta last reported holding, valued at $45.89, the price Ordinary Shares was last bought or sold at on the open market here, on 2 Jul 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Kapusta Matthew C
CEO, Managing Director
$50.18M (138) scheduled
−$50.18M
519,227
0.7485%
$23.83M
+125.2%
Kuta Alexander Edward III
Executive VP, Operations
$5.14M (38) scheduled
−$5.14M
90,381
0.1303%
$4.15M
Gut Robert
Director
$4.96M (24) scheduled
−$4.96M
32,259
0.0465%
$1.48M
KLEMT CHRISTIAN
Chief Financial Officer
$4.79M (32)
−$4.79M
226,581
0.3266%
$10.40M
+885.1%
Kaye Jack
Director
$2.96M (18) scheduled
−$2.96M
25,996
0.0375%
$1.19M
Abi-Saab Walid
Chief Medical Officer
$2.65M (10) scheduled
−$2.65M
148,235
0.2137%
$6.80M
+120.6%
Soteropoulos Paula
Director
$1.92M (19)
−$1.92M
20,203
0.0291%
$927.12K
+26.3%
Astley-Sparke Philip
Director
$1.51M (14)
−$1.51M
9,946
0.0143%
$456.42K
−66.8%
Balachandran Madhavan
Director
$1.07M (13) scheduled
−$1.07M
43,254
0.0624%
$1.98M
Zelenkofske Steven
Chief Medical Officer
$888.72K (1)
−$888.72K
159,458
0.2299%
$7.32M
Petry Harald
Chief Scientific Officer
$846.06K (6) scheduled
−$846.06K
0
0.0000%
$0.00
Dolmetsch Ricardo
President, R&D
$590.56K (6)
−$590.56K
163,404
0.2356%
$7.50M
CALOZ PIERRE
Chief Operating Officer
$574.06K (9)
−$574.06K
115,707
0.1668%
$5.31M
O'Keefe Kylie
Chief Customer & Strat Officer
$431.23K (1)
−$431.23K
108,864
0.1569%
$5.00M
+3.7%
Potts Jeannette
Chief Legal Officer
$428.50K (6)
−$428.50K
133,246
0.1921%
$6.11M
SCHAFFER DAVID
Director
$371.73K (4)
−$371.73K
46,978
0.0677%
$2.16M
−12.0%
van Deventer Sander
EVP, Research & Product Dev.
$290.64K (4)
−$290.64K
102,512
0.1478%
$4.70M
+88.7%
Springhorn Jeremy P.
Director
$263.95K (10)
−$263.95K
43,251
0.0624%
$1.98M
Meek David D.
Director
$220.59K (9)
−$220.59K
39,747
0.0573%
$1.82M
POST LEONARD E
Director
$159.91K (6)
−$159.91K
35,494
0.0512%
$1.63M
Jacques Rachelle Suzanne
Director
$146.72K (5)
−$146.72K
33,903
0.0489%
$1.56M
Cantor Maria E
SVP, Investor Rel. & Comm.
$118.03K (1)
−$118.03K
92,439
0.1333%
$4.24M
+164.1%
Firuta Paul E
Chief Commercial Officer
$118.03K (1)
−$118.03K
93,817
0.1352%
$4.31M
+168.0%
Garen Jonathan
Chief Business Officer
$118.03K (1)
−$118.03K
93,638
0.1350%
$4.30M
+167.5%
McMillan Scott T.
Chief Operating Officer
$18.46K (1)
−$18.46K
20,432
0.0295%
$937.62K
+16,786%
Insider
Date
Role
Action
Shares
Price
Amount
Kapusta Matthew C
2 Jul 2026
CEO, Managing Director
Sold after exercise
7,600
$45.89
$348.76K
Kapusta Matthew C
2 Jul 2026
CEO, Managing Director
Sold after exercise
4,282
$45.43
$194.53K
Kapusta Matthew C
2 Jul 2026
CEO, Managing Director
Sold after exercise
9,200
$44.43
$408.76K
Kaye Jack
30 Jun 2026
Director
Sold after exercise
17,060
$46.43
$792.10K
Kaye Jack
30 Jun 2026
Director
Sold after exercise
4,107
$46.49
$190.93K
Abi-Saab Walid
30 Jun 2026
Chief Medical Officer
Sold after exercise
20,000
$46.40
$928.00K
Abi-Saab Walid
30 Jun 2026
Chief Medical Officer
Sold after exercise
10,000
$46.46
$464.60K
Kapusta Matthew C
25 Jun 2026
CEO, Managing Director
Sold after exercise
28,716
$50.02
$1.44M
Kapusta Matthew C
24 Jun 2026
CEO, Managing Director
Sold after exercise
6,696
$50.00
$334.80K
Kapusta Matthew C
18 Jun 2026
CEO, Managing Director
Sold after exercise
37,015
$50.00
$1.85M
Kapusta Matthew C
18 Jun 2026
CEO, Managing Director
Sold after exercise
4,656
$50.00
$232.80K
Kaye Jack
17 Jun 2026
Director
Sold after exercise
5,295
$42.57
$225.41K
Balachandran Madhavan
17 Jun 2026
Director
Sold after exercise
1,690
$42.60
$71.99K
Balachandran Madhavan
17 Jun 2026
Director
Sold after exercise
4,700
$43.66
$205.20K
Balachandran Madhavan
17 Jun 2026
Director
Sold after exercise
5,295
$47.08
$249.29K
Kapusta Matthew C
17 Jun 2026
CEO, Managing Director
Sold after exercise
11,585
$48.65
$563.61K
Kapusta Matthew C
17 Jun 2026
CEO, Managing Director
Sold after exercise
33,334
$45.01
$1.50M
Kapusta Matthew C
17 Jun 2026
CEO, Managing Director
Sold after exercise
56,929
$43.43
$2.47M
Kapusta Matthew C
17 Jun 2026
CEO, Managing Director
Sold after exercise
32,581
$45.02
$1.47M
Kapusta Matthew C
17 Jun 2026
CEO, Managing Director
Sold after exercise
6,023
$43.70
$263.21K
Kapusta Matthew C
17 Jun 2026
CEO, Managing Director
Sold after exercise
23,977
$42.61
$1.02M
Balachandran Madhavan
15 Jun 2026
Director
Sold after exercise
10,000
$27.85
$278.50K
Gut Robert
10 Jun 2026
Director
Sold after exercise
1,780
$26.05
$46.37K
Gut Robert
10 Jun 2026
Director
Sold after exercise
3,127
$26.03
$81.40K
Gut Robert
10 Jun 2026
Director
Sold after exercise
2,645
$26.07
$68.96K
Kaye Jack
3 Jun 2026
Director
Sold after exercise
2,645
$30.01
$79.38K
Abi-Saab Walid
8 May 2026
Chief Medical Officer
Sold after exercise
20,000
$25.00
$500.00K
Abi-Saab Walid
8 May 2026
Chief Medical Officer
Sold after exercise
25,000
$25.10
$627.50K
Gut Robert
12 Jan 2026
Director
Sold after exercise
7,803
$25.09
$195.78K
Gut Robert
12 Jan 2026
Director
Sold after exercise
500
$25.03
$12.52K
Gut Robert
12 Jan 2026
Director
Sold after exercise
17,310
$24.39
$422.19K
Kaye Jack
9 Jan 2026
Director
Sold after exercise
6,390
$27.28
$174.32K
Gut Robert
6 Nov 2025
Director
Sold after exercise
15,594
$27.30
$425.72K
Gut Robert
6 Nov 2025
Director
Sold after exercise
15,840
$27.22
$431.16K
Kaye Jack
4 Nov 2025
Director
Sold after exercise
17,810
$30.33
$540.18K
Kaye Jack
4 Nov 2025
Director
Sold after exercise
11,000
$30.34
$333.74K
Kaye Jack
4 Nov 2025
Director
Sold after exercise
10,000
$30.36
$303.60K
KLEMT CHRISTIAN
26 Sep 2025
Chief Financial Officer
Sold after exercise
15,000
$55.00
$825.00K
KLEMT CHRISTIAN
24 Sep 2025
Chief Financial Officer
Sold after exercise
3,000
$40.04
$120.12K
Kapusta Matthew C
24 Sep 2025
CEO, Managing Director
Sold after exercise
60,000
$45.10
$2.71M
Kapusta Matthew C
24 Sep 2025
CEO, Managing Director
Sold after exercise
5,022
$41.69
$209.37K
Kapusta Matthew C
24 Sep 2025
CEO, Managing Director
Sold after exercise
49,978
$40.68
$2.03M
Kapusta Matthew C
24 Sep 2025
CEO, Managing Director
Sold after exercise
60,000
$40.04
$2.40M
Kapusta Matthew C
24 Sep 2025
CEO, Managing Director
Sold after exercise
51,316
$39.59
$2.03M
Kapusta Matthew C
10 Dec 2024
CEO, Managing Director
Sold after exercise
100,000
$15.03
$1.50M
Soteropoulos Paula
18 Jan 2023
Director
Sold after exercise
6,000
$22.59
$135.54K
Soteropoulos Paula
14 Dec 2022
Director
Sold after exercise
3,800
$23.43
$89.03K
Soteropoulos Paula
13 Dec 2022
Director
Sold after exercise
3,000
$23.45
$70.35K
Soteropoulos Paula
29 Nov 2022
Director
Sold after exercise
6,200
$25.38
$157.36K
Kuta Alexander Edward III
28 Jul 2022
Executive VP, Operations
Sold after exercise
406
$25.01
$10.15K
Kuta Alexander Edward III
28 Jul 2022
Executive VP, Operations
Sold after exercise
26,952
$25.00
$673.80K
Kuta Alexander Edward III
27 Jul 2022
Executive VP, Operations
Sold after exercise
10,404
$25.00
$260.10K
Kuta Alexander Edward III
22 Jul 2022
Executive VP, Operations
Sold after exercise
5,643
$25.00
$141.08K
Kuta Alexander Edward III
21 Jul 2022
Executive VP, Operations
Sold after exercise
595
$25.00
$14.88K
Kuta Alexander Edward III
15 Dec 2021
Executive VP, Operations
Sold after exercise
6,000
$27.90
$167.40K
Kuta Alexander Edward III
15 Nov 2021
Executive VP, Operations
Sold after exercise
6,000
$31.81
$190.86K
Kuta Alexander Edward III
15 Oct 2021
Executive VP, Operations
Sold after exercise
6,000
$30.65
$183.90K
Kuta Alexander Edward III
15 Sep 2021
Executive VP, Operations
Sold after exercise
6,000
$36.32
$217.92K
Kuta Alexander Edward III
16 Aug 2021
Executive VP, Operations
Sold after exercise
6,000
$28.84
$173.04K
Kuta Alexander Edward III
15 Jul 2021
Executive VP, Operations
Sold after exercise
6,000
$27.22
$163.32K
Kuta Alexander Edward III
15 Jun 2021
Executive VP, Operations
Sold after exercise
6,000
$35.43
$212.58K
Kuta Alexander Edward III
17 May 2021
Executive VP, Operations
Sold after exercise
6,000
$31.66
$189.96K
Kuta Alexander Edward III
15 Apr 2021
Executive VP, Operations
Sold after exercise
6,000
$35.06
$210.36K
Kapusta Matthew C
16 Dec 2020
CEO, CFO, Managing Director
Sold after exercise
1,786
$48.83
$87.21K
Kapusta Matthew C
16 Dec 2020
CEO, CFO, Managing Director
Sold after exercise
10,715
$48.34
$517.96K
Kapusta Matthew C
19 Nov 2020
CEO, CFO, Managing Director
Sold after exercise
11,355
$45.18
$513.02K
Kapusta Matthew C
18 Nov 2020
CEO, CFO, Managing Director
Sold after exercise
600
$44.71
$26.83K
Kapusta Matthew C
18 Nov 2020
CEO, CFO, Managing Director
Sold after exercise
5,776
$43.98
$254.03K
Kapusta Matthew C
18 Nov 2020
CEO, CFO, Managing Director
Sold after exercise
3,937
$43.11
$169.72K
Gut Robert
23 Jun 2020
Chief Medical Officer
Sold after exercise
26,875
$70.00
$1.88M
KLEMT CHRISTIAN
24 Apr 2020
Chief Accounting Officer
Sold after exercise
2,250
$60.00
$135.00K
Kapusta Matthew C
22 Apr 2020
CEO, CFO, Managing Director
Sold after exercise
1,200
$57.34
$68.81K
Kapusta Matthew C
22 Apr 2020
CEO, CFO, Managing Director
Sold after exercise
8,176
$56.80
$464.40K
Kapusta Matthew C
18 Mar 2020
CEO, CFO, Managing Director
Sold after exercise
200
$43.70
$8.74K
Kapusta Matthew C
18 Mar 2020
CEO, CFO, Managing Director
Sold after exercise
1,438
$42.40
$60.97K
Showing 250 of 377 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 393
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 98
Sales at will 277
Transactions with no price 0
Shares from compensation/vesting 4,173,485
Sales filed before the plan box existed 213
History held since 31 Jan 2017